Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 325 of 500 entries
View as:

A Study to Investigate the Contraceptive Efficacy and Safety of a Subdermal Etonogestrel Implant (Implanon®)(P06473)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00725413 Org: User:
Start: 11/30/01 End: 11/30/05 Due: 11/30/06

Nasonex® Nasal Suspension 50 μg Long-term Designated Drug Use Investigation (Study P05876)

Phase: N/A Priority: Normal
NCT ID: NCT00903721 Org: User:
Start: 11/30/08 End: 10/31/12 Due: 10/31/13

Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04207)

Phase: N/A Priority: Normal
NCT ID: NCT00817050 Org: User:
Start: 12/01/04 End: 01/01/05 Due: 01/01/06

Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00337675 Org: User:
Start: 10/31/06 End: 08/31/09 Due: 08/31/10

Finasteride (MK-0906) and Male Breast Cancer - A Register-Based Nested Case-Control Study (MK-0906-162/2003.021).

Phase: N/A Priority: Normal
NCT ID: NCT01703520 Org: User:
Start: 05/01/11 End: 11/30/17 Due: 11/30/18

Quality of Life With Arcoxia in Women With Dysmenorrhea (0663-094)

Phase: N/A Priority: Normal
NCT ID: NCT00380627 Org: User:
Start: 09/01/05 End: 01/31/06 Due: 01/31/07

Study for the Treatment of Chronic Idiopathic Urticaria With High Doses of AERIUS (Desloratadine) (Study P04849)

Phase: N/A Priority: Normal
NCT ID: NCT00536380 Org: User:
Start: 09/30/07 End: 04/30/09 Due: 04/30/10

Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)

Phase: N/A Priority: Normal
NCT ID: NCT00092560 Org: User:
Start: 12/31/02 End: 12/31/03 Due: 12/31/04

Assessment of Potential Interaction Between Ezetimibe and Rosuvastatin in Healthy Subjects With High Cholesterol (P03317)

Phase: N/A Priority: Normal
NCT ID: NCT00651144 Org: User:
Start: 03/31/03 End: 05/31/03 Due: 05/31/04

Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)

Phase: N/A Priority: Normal
NCT ID: NCT02524288 Org: User:
Start: 08/31/15 End: 09/16/16 Due: 09/16/17

Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)

Phase: N/A Priority: Normal
NCT ID: NCT00380705 Org: User:
Start: 03/18/05 End: 07/29/05 Due: 07/29/06

Eze/Simva Switch Study in Diabetics (0653A-807)

Phase: N/A Priority: Normal
NCT ID: NCT00541697 Org: User:
Start: 01/19/05 End: 10/14/05 Due: 10/14/06

An Approved Drug to Study a New Indication for Allergic Rhinitis (0476-327)

Phase: N/A Priority: Normal
NCT ID: NCT00127647 Org: User:
Start: 11/30/04 End: 04/30/05 Due: 04/30/06

TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060)

Phase: N/A Priority: Normal
NCT ID: NCT00328523 Org: User:
Start: 06/30/04 End: 01/31/06 Due: 01/31/07

Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058)

Phase: N/A Priority: Normal
NCT ID: NCT00090298 Org: User:
Start: 04/30/04 End: 12/31/04 Due: 12/31/05

Singulair(R) In Asthma And Allergic Rhinitis (0476-383)

Phase: N/A Priority: Normal
NCT ID: NCT00545844 Org: User:
Start: 04/01/07 End: 01/01/08 Due: 01/01/09

A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00652301 Org: User:
Start: 07/31/03 End: 04/30/04 Due: 04/30/05

Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)

Phase: N/A Priority: Normal
NCT ID: NCT00092599 Org: User:
Start: 02/28/03 End: 07/31/04 Due: 07/31/05

A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem (0653A-808)

Phase: N/A Priority: Normal
NCT ID: NCT00132717 Org: User:
Start: 01/01/05 End: 06/01/07 Due: 06/01/08

First Step With Singulair® Therapy (0476-323)

Phase: N/A Priority: Normal
NCT ID: NCT00545324 Org: User:
Start: 09/30/02 End: 12/31/03 Due: 12/31/04

Comparing an Investigational Medication Versus an Approved Medication in Reducing Cholesterol Levels (0653-025)

Phase: N/A Priority: Normal
NCT ID: NCT00092716 Org: User:
Start: 05/31/02 End: 04/30/03 Due: 04/30/04

A Research Study to Evaluate the Safety and Effectiveness of MK0217 to Prevent and Treat Bone Loss (0217-193)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00480766 Org: User:
Start: 07/31/01 End: 08/31/03 Due: 08/31/04

Etoricoxib vs. Diclofenac in OA (0663-805)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00542087 Org: User:
Start: 03/22/02 End: 12/20/02 Due: 12/20/03

A Long-term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis (Study P04459)

Phase: N/A Priority: Normal
NCT ID: NCT00732368 Org: User:
Start: 05/01/05 End: 01/01/06 Due: 01/01/07

A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00140972 Org: User:
Start: 12/03/04 End: 06/27/05 Due: 06/27/06